血液衰老生物标志物指数与死亡及慢性病的关联:心血管健康研究
经6年随访,BI每升高一个类别,女性死亡或慢性病复合结局的HR为1.65(95%CI 1.52–1.80),男性为1.75(95%CI 1.58–1.94);BI可使年龄对该复合结局的效应在女性中减弱16.7%、男性中减弱22.0%。
要点
- BI每升高一个类别,女性复合结局HR为1.65(95%CI 1.52–1.80),男性为1.75(95%CI 1.58–1.94)。
- 年龄每增加5岁,女性HR为1.57(95%CI 1.48–1.67),男性为1.55(95%CI 1.44–1.67)。
- BI可使年龄对复合结局的效应在女性中减弱16.7%、男性中减弱22.0%。
核心结论
- BI与死亡及慢性病(心血管疾病、痴呆、癌症)复合结局显著且独立相关,并可减弱年龄的效应。
- 由血浆标志物构成的BI可能是干预衰老进程的实用中间表型。
研究设计与样本
- BI纳入胰岛素样生长因子-1、白细胞介素-6、氨基末端脑钠肽前体、胱抑素-C、C反应蛋白、肿瘤坏死因子-α可溶性受体1、空腹胰岛素和空腹血糖,依据其与死亡的关系构建。
- 采用Cox比例风险模型预测死亡与慢性病(心血管疾病、痴呆、癌症)的复合结局。
主要发现
- BI每升高一个类别,复合结局的HR(95%CI)在女性为1.65(1.52, 1.80),男性为1.75(1.58, 1.94)。
- 年龄每增加5岁,HR(95%CI)在女性为1.57(1.48, 1.67),男性为1.55(1.44, 1.67)。
- BI可使年龄对复合结局的效应在女性中减弱16.7%、男性中减弱22.0%。
关键数值与推荐
- BI每升高一个类别对应的复合结局HR(95%CI):女性1.65(1.52, 1.80),男性1.75(1.58, 1.94)。
- 年龄每5岁对应的HR(95%CI):女性1.57(1.48, 1.67),男性1.55(1.44, 1.67)。
- BI对年龄效应的减弱幅度:女性16.7%,男性22.0%。
临床怎么用
- 可将由血浆标志物构成的BI作为评估衰老相关风险的中间表型参考。
- 对BI升高的老年人,可更关注死亡及心血管疾病、痴呆、癌症等慢性病复合风险。
局限性
- 原文未报告BI各标志物的具体权重、阈值或评分方法。
- 原文未报告BI与单一疾病结局的关联及队列人群外推性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A goal of gerontology is to discover phenotypes that reflect biological aging distinct from disease pathogenesis. Biomarkers that are strongly associated with mortality could be used to define such a phenotype. However, the relation of such an index with multiple chronic conditions warrants further exploration. METHODS: A biomarker index (BI) was constructed in the Cardiovascular Health Study (N = 3 197), with a mean age of 74 years. The BI incorporated circulating levels of new biomarkers, including insulin-like growth factor-1, interleukin-6, amino-terminal pro-B-type natriuretic peptide, cystatin-C, C-reactive protein, tumor necrosis factor-alpha soluble receptor 1, fasting insulin, and fasting glucose, and was built based on their relationships with mortality. Cox proportional hazards models predicting a composite of death and chronic disease involving cardiovascular disease, dementia, and cancer were calculated with 6 years of follow-up. RESULTS: The hazard ratio (HR, 95% CI) for the composite outcome of death or chronic disease per category of BI was 1.65 (1.52, 1.80) and 1.75 (1.58, 1.94) in women and men, respectively. The HR (95% CI) per 5 years of age was 1.57 (1.48, 1.67) and 1.55 (1.44, 1.67) in women and men, respectively. Moreover, BI could attenuate the effect of age on the composite outcome by 16.7% and 22.0% in women and men, respectively. CONCLUSIONS: Biomarker index was significantly and independently associated with a composite outcome of death and chronic disease, and attenuated the effect of age. The BI that is composed of plasma biomarkers may be a practical intermediate phenotype for interventions aiming to modify the course of aging.
引用
- Zhang X, Sanders JL, Boudreau RM, et al. Association of a Blood-Based Aging Biomarker Index With Death and Chronic Disease: Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci. 2024. PMID: 37464278. doi:10.1093/gerona/glad172
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。